» Articles » PMID: 38371330

Optimal Personalized Treatment Selection with Multivariate Outcome Measures in a Multiple Treatment Case

Overview
Date 2024 Feb 19
PMID 38371330
Authors
Affiliations
Soon will be listed here.
Abstract

In this work we propose a novel method for individualized treatment selection when there are correlated multiple treatment responses. For the treatment ( ≥ 2) scenario, we compare quantities that are suitable indexes based on outcome variables for each treatment conditional on patient-specific scores constructed from collected covariate measurements. Our method covers any number of treatments and outcome variables, and it can be applied for a broad set of models. The proposed method uses a rank aggregation technique that takes into account possible correlations among ranked lists to estimate an ordering of treatments based on treatment performance measures such as the smooth conditional mean. The method has the flexibility to incorporate patient and clinician preferences into the optimal treatment decision on an individual case basis. A simulation study demonstrates the performance of the proposed method in finite samples. We also present data analyses using HIV clinical trial data to show the applicability of the proposed procedure for real data.

References
1.
Johnson P, Greiner W, Al-Dakkak I, Wagner S . Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies?. Biomed Res Int. 2015; 2015:865101. PMC: 4486603. DOI: 10.1155/2015/865101. View

2.
Hammer S, Katzenstein D, Hughes M, Gundacker H, Schooley R, Haubrich R . A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med. 1996; 335(15):1081-90. DOI: 10.1056/NEJM199610103351501. View

3.
Unnikrishnan A, Bhattacharyya A, Baruah M, Sinha B, Dharmalingam M, Rao P . Importance of achieving the composite endpoints in diabetes. Indian J Endocrinol Metab. 2013; 17(5):835-43. PMC: 3784866. DOI: 10.4103/2230-8210.117225. View

4.
Siriwardhana C, Datta S, Kulasekera K . Selection of the optimal personalized treatment from multiple treatments with multivariate outcome measures. J Biopharm Stat. 2019; 30(3):462-480. DOI: 10.1080/10543406.2019.1684304. View

5.
Butler E, Laber E, Davis S, Kosorok M . Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules. Biometrics. 2017; 74(1):18-26. PMC: 5785589. DOI: 10.1111/biom.12743. View